Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses
- PMID: 32957440
- PMCID: PMC7557740
- DOI: 10.3390/jof6030173
Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses
Abstract
During the last few decades, mucormycosis has emerged as one of the most common fungal infections, following candidiasis and aspergillosis. The fungal order responsible for causing mucormycosis is the Mucorales. The main hallmarks of this infection include the invasion of blood vessels, infarction, thrombosis, and tissue necrosis, which are exhibited at the latest stages of the infection. Therefore, the diagnosis is often delayed, and the rapid progression of the infection severely endangers the life of people suffering from diabetes mellitus, hematological malignancies, or organ transplantation. Given the fact that mortality rates for mucormycosis range from 40 to 80%, early diagnosis and novel therapeutic strategies are urgently needed to battle the infection. However, compared to other fungal infections, little is known about the host immune response against Mucorales and the influence of inflammatory processes on the resolution of the infection. Hence, in this review, we summarized our current understanding of the interplay among pro-inflammatory cytokines, chemokines, and the host-immune cells in response to mucoralean fungi, as well as their potential use for immunotherapies.
Keywords: Lichtheimia; Mucor; Mucoromycotina; Rhizomucor; Rhizopus; epi- and endothelium; innate immune system; macrophages; monocytes; phagocytes; phagocytosis; zygomycosis.
Conflict of interest statement
The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.
Figures
References
-
- Skiada A., Lanternier F., Groll A.H., Pagano L., Zimmerli S., Herbrecht R., Lortholary O., Petrikkos G.L. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3) Haematologica. 2013;98:492–504. doi: 10.3324/haematol.2012.065110. - DOI - PMC - PubMed
-
- Skiada A., Pagano L., Groll A., Zimmerli S., Dupont B., Lagrou K., Lass-Florl C., Bouza E., Klimko N., Gaustad P., et al. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin. Microbiol. Infect. 2011;17:1859–1867. doi: 10.1111/j.1469-0691.2010.03456.x. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
